1. Home
  2. TASK vs CTMX Comparison

TASK vs CTMX Comparison

Compare TASK & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TASK

TaskUs Inc.

HOLD

Current Price

$8.18

Market Cap

755.5M

Sector

Technology

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$2.70

Market Cap

716.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TASK
CTMX
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
755.5M
716.9M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
TASK
CTMX
Price
$8.18
$2.70
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
★ $14.70
$12.10
AVG Volume (30 Days)
440.0K
★ 3.9M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 120.00
N/A
EPS
★ 0.50
N/A
Revenue
N/A
★ $76,201,000.00
Revenue This Year
$5.95
N/A
Revenue Next Year
$6.46
$7.61
P/E Ratio
★ $15.96
$22.58
Revenue Growth
★ N/A
N/A
52 Week Low
$4.47
$2.67
52 Week High
$17.94
$8.21

Technical Indicators

Market Signals
Indicator
TASK
CTMX
Relative Strength Index (RSI) 53.94 35.21
Support Level $7.46 N/A
Resistance Level $8.18 $3.93
Average True Range (ATR) 0.38 0.19
MACD -0.05 -0.05
Stochastic Oscillator 51.87 5.00

Price Performance

Historical Comparison
TASK
CTMX

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: